| 1 |
34897963 | Effect of lanthanum carbonate on the progression of coronary artery calcification in hemodialysis patients: A meta-analysis of randomized controlled trials. | 2022 Apr |
1 |
| 2 |
29748907 | Effect of combined vitamin D receptor activator and lanthanum carbonate on serum fibroblast growth factor 23 level in predialysis patients (CVD-LAF study): design and method. | 2018 Dec |
2 |
| 3 |
27928636 | Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients. | 2017 Oct |
1 |
| 4 |
28233139 | Erratum to: Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients. | 2017 Oct |
1 |
| 5 |
24885942 | Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial. | 2014 May 5 |
2 |
| 6 |
23391319 | The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients. | 2013 Jul |
4 |
| 7 |
21771755 | Combined therapy with lanthanum carbonate and calcium carbonate for hyperphosphatemia decreases serum FGF-23 level independently of calcium and PTH (COLC Study). | 2012 Mar |
3 |
| 8 |
21436379 | Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients. | 2011 Aug |
3 |